Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion

Identifieur interne : 002658 ( Main/Exploration ); précédent : 002657; suivant : 002659

Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion

Auteurs : Birgit Meiler [Allemagne] ; Jürgen Andrich [Allemagne] ; Thomas Müller [Allemagne]

Source :

RBID : ISTEX:5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3

Descripteurs français

English descriptors

Abstract

Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society

Url:
DOI: 10.1002/mds.21800


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title>
<author>
<name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name>
</author>
<author>
<name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name>
</author>
<author>
<name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21800</idno>
<idno type="url">https://api.istex.fr/document/5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003A52</idno>
<idno type="wicri:Area/Istex/Curation">003A52</idno>
<idno type="wicri:Area/Istex/Checkpoint">001214</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Meiler B:rapid:switch:from</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17987653</idno>
<idno type="wicri:Area/PubMed/Corpus">002459</idno>
<idno type="wicri:Area/PubMed/Curation">002459</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002109</idno>
<idno type="wicri:Area/Ncbi/Merge">001F00</idno>
<idno type="wicri:Area/Ncbi/Curation">001F00</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001F00</idno>
<idno type="wicri:Area/Main/Merge">003236</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0115914</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001399</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001920</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001110</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Meiler B:rapid:switch:from</idno>
<idno type="wicri:Area/Main/Merge">003718</idno>
<idno type="wicri:Area/Main/Curation">002658</idno>
<idno type="wicri:Area/Main/Exploration">002658</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title>
<author>
<name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea>
<wicri:noRegion>44791 Bochum</wicri:noRegion>
<wicri:noRegion>44791 Bochum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea>
<wicri:noRegion>44791 Bochum</wicri:noRegion>
<wicri:noRegion>44791 Bochum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea>
<wicri:noRegion>44791 Bochum</wicri:noRegion>
<wicri:noRegion>44791 Bochum</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-01">2008-01</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="145">145</biblScope>
<biblScope unit="page" to="146">146</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3</idno>
<idno type="DOI">10.1002/mds.21800</idno>
<idno type="ArticleID">MDS21800</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Administration, Oral</term>
<term>Aged</term>
<term>Combined treatment</term>
<term>Drug Therapy, Combination</term>
<term>Drug combination</term>
<term>Duodenum</term>
<term>Female</term>
<term>Humans</term>
<term>Infusions, Parenteral</term>
<term>Jejunostomy</term>
<term>Levodopa</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Nervous system diseases</term>
<term>Oral administration</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Time Factors</term>
<term>levodopa infusion</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Administration, Oral</term>
<term>Aged</term>
<term>Drug Therapy, Combination</term>
<term>Duodenum</term>
<term>Female</term>
<term>Humans</term>
<term>Infusions, Parenteral</term>
<term>Jejunostomy</term>
<term>Male</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Association médicamenteuse</term>
<term>Duodénum</term>
<term>Lévodopa</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Traitement associé</term>
<term>Voie orale</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
</list>
<tree>
<country name="Allemagne">
<noRegion>
<name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name>
</noRegion>
<name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name>
<name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002658 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002658 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3
   |texte=   Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024